Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

著者: Paolo Curatolo, David Neal Franz, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Petrus J. de Vries, Dennis Dlugos, Jenna Fan, Antonia Ridolfi, Diana Pelov, Maurizio Voi, Jacqueline A. French - The Lancet 2018 被引用: 116